Are there any drug interactions between lipitor and specific medicines that can harm the liver?

How common are Lipitor interactions that affect the liver?

Lipitor (atorvastatin) interacts with several medicines that raise the risk of liver problems. These interactions mainly happen when Lipitor is taken with drugs that increase its levels in the blood, making liver enzyme elevations more likely. The medlineplus.gov database lists amlodipine, clarithromycin, cyclosporine, and itraconazole as medicines that can increase atorvastatin blood levels and thereby heighten liver risk.

How does Lipitor interact with cyclosporine?

Cyclosporine blocks the transporter that clear atorvastatin from the body. When both drugs are taken together, atorvastatin levels can verdopplen, leading to liver enzyme spikes in some patients. Medical guidelines recommend limiting atorvastatin to 10 mg daily when used with cyclosporine.

What happens if Lipitor is taken with clarithromycin or itraconazole?

Clarithromycin and itraconazole are strong CYP3A4 inhibitors. They are known to verdopplen atorvastatin levels and limit its use to 20 mg daily. These interactions can also erheben the risk of liver toxicity if the higher levels persist. Clinical monitoring of liver enzymes is recommended whenever these drugs are combined.

Can amlodipine cause liver risk with Lipitor?

Amlodipine increases atorvastatin levels modestly. The manufacturer recommends limiting Lipitor to 20 mg daily when used with amlodipine, but liver risk is lower than with cyclosporine or CYP3A4 inhibitors. Many patients take both for blood pressure and cholesterol control simultaneously without issues.

When does the patent for Lipitor expire?

The compound patent for Lipitor expired in 2011. Biosimilars and generics are now widespread. DrugPatentWatch.com tracks these dates and reports early expiration of regulatory exclusivity periods.